Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

39.27 -0.09 (-0.22%)
Streaming Delayed Price Updated: 1:22 PM EDT, Jul 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Gsk Plc ADR

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
5 Best Dividend Stocks To Buy Now
There's no better time than now to invest in dividend stocks. And some of the best dividend stocks that beat the S&P 500's average yield of 2% can be found in the healthcare sector. 
Via Talk Markets
Topics Stocks
Exposures US Equities
3 Big Drug/Biotech Outperformers Worth Keeping an Eye On
The second-quarter earnings season was a strong one for the drug/biotech sector. 
Via Talk Markets
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday. 
Via Investor's Business Daily
Merck KGaA Pulls Plug On GSK-Partnered Cancer Drug Trial
Merck KGaA's (OTC: MKGAF) announced that a Phase 2 trial of bintrafusp alfa had been discontinued, as an independent data monitoring committee has determined the... 
Via Benzinga
Vir Biotech-GSK's COVID-19 Treatment Wins Provisional Approval In Australia
The Australian Therapeutic Goods Administration has granted provisional marketing authorization for Vir Biotechnology Inc's (NASDAQ: VIR) for sotrovimab,... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Unusual Options Activity Insight: GlaxoSmithKline
Shares of GlaxoSmithKline (NYSE:GSK) saw some unusual option... 
Via Benzinga
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues,... 
Via Benzinga
Exposures Product Safety
2 SPACs That Look Like Bargains After Post-Earnings Drops
Many recent SPAC IPOs have been hammered, and these two could be worth a closer look. 
Via The Motley Fool
After FDA Rejection, EMA Approves FibroGen-Astellas' Roxadustat
The European Commission (EC) has approved FibroGen Inc (NASDAQ: FGEN) and Astellas Pharma's (OTC: ALPMF) Evrenzo (roxadustat) for anemia caused by... 
Via Benzinga
Exposures Product Safety
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet. 
Via The Motley Fool
Exposures COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
GlaxoSmithKline PLC Looks To Continue To Trade Above Its Annual-High Share Price Today
GlaxoSmithKline PLC (NYSE: GSK) traded at a new 52-week high today of $42.68. This new high was reached on below-average trading volume as 1.4 million shares traded hands, while... 
Via Benzinga
AnaptysBio-Generated Antibody Scores Second FDA Approval For Solid Tumor Indication
The FDA has approved a second indication for GlaxoSmithKline plc's (NYSE: GSK) Jemperli (dostarlimab-gxly). The approval comes for adult patients with... 
Via Benzinga
Exposures Product Safety
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs. Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market cap to set a new 52-week... 
Via Benzinga
4 High-Yield Dividend Stocks to Boost Your Dividend Income
Dividends paid by GlaxoSmithKline plc, Vector Group Ltd, Star Group, L.P., and Ennis, Inc translate to high yields at their current price levels. 
Via Talk Markets
Large Cap Biopharma Stocks provide Growth and Value
The S&P 500 Healthcare Index was up 0.53% and biotech still lags in healthcare yet Large Cap Biopharma is doing well YTD. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Sunday Update - UK Disarray, Brazilian Kisses
News from the UK, China and Brazil, with the latest from Cosan. 
Via Talk Markets
Friday the Thirteenth
The stock week in points eastward was mixed. The USA markets face a bear correction. 
Via Talk Markets
82 Firms Going Ex-Dividend Next Week, Including Target, Walgreens Boots Alliance and GlaxoSmithKline
There are several well-known large-cap stocks going ex-dividend next week. 
Via Talk Markets
Do mRNA COVID-19 Vaccines Cause Skin Or Kidney Disorders? EMA Investigates Possible Links
The European Medicines Agency is investing a possible link between mRNA vaccines and erythema multiforme or two kidney disorders by a few recipients of the shots.... 
Via Benzinga
Exposures COVID-19
The Real World
The rise of the delta has caused markets to drop back after the rises earlier although inflation still remains within a point or two of forecasts at 5.3-5.4% annualized. 
Via Talk Markets
Know When To Hold 'Em, Know When To Fold 'Em ...
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
GlaxoSmithKline Files US Application For Approval Of Its MMR Vaccine
GlaxoSmithKline Plc (NYSE: GSK) has submitted a marketing application to the FDA seeking approval for PRIORIX for use in active immunization against infection by... 
Via Benzinga
Exposures Product Safety
Cannabis Movers & Shakers: BioHarvest Sciences, Green Hygienics, Realm of Caring, Media Central Corp, Al Harrington's Viola
BioHarvest Sciences Appoints Two Law Firms To Pursue Regulatory Approvals of Its Upcoming Cannabis and Hemp Products ... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Barron's Latest Picks And Pans: American Express, GE, GlaxoSmithKline, Intel And More
This weekend's Barron's offers investors an overlooked way to play the coming infrastructure surge. Other featured articles discuss how to find rising dividends, why some... 
Via Benzinga
GlaxoSmithKline's Scores FDA Approval For First IL-5 Inhibitor In Nasal Polyps
The FDA approved GlaxoSmithKline Plc's (NYSE: GSK) Nucala (mepolizumab) for chronic rhinosinusitis with nasal polyps, making it the first IL-5 inhibitor to... 
Via Benzinga
Exposures Product Safety
News Overload
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
Avoid These 7 Stocks in Retirement Like the Plague
By, Bob Ciura Investors who are in retirement, or nearing retirement will have different needs than their younger counterparts still in the accumulation phase of their life.... 
Via Benzinga
Topics Retirement
Exposures Pension
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.